ASH 2018: Bispecific T-cell Engangers (BiTEs)

ASH 2018: Bispecific T-cell Engangers (BiTEs)

Bispecific T-cell engagers in the treatment of myelomaПодробнее

Bispecific T-cell engagers in the treatment of myeloma

ASH 2018: MaintenanceПодробнее

ASH 2018: Maintenance

ASH 2018: MRD in RelapseПодробнее

ASH 2018: MRD in Relapse

ASH 2018: Blood MonitoringПодробнее

ASH 2018: Blood Monitoring

ASH 2018: Frontline TherapyПодробнее

ASH 2018: Frontline Therapy

ASH 2018: CAR T-cell TherapyПодробнее

ASH 2018: CAR T-cell Therapy